logo
Home  > (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one

AB45848

50-02-2 | (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one

Packsize Purity Availability Price Discounted Price    Quantity
1g 98% in stock $18.00 $12.00 -   +
5g 98% in stock $40.00 $28.00 -   +

*All products are for research use only and not intended for human or animal use.

*All prices are in USD.

Description
Catalog Number: AB45848
Chemical Name: (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
CAS Number: 50-02-2
Molecular Formula: C22H29FO5
Molecular Weight: 392.4611
MDL Number: MFCD00064136
SMILES: OCC(=O)[C@@]1(O)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F
NSC Number: 34521

 

Computed Properties
Complexity: 805  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 8  
Heavy Atom Count: 28  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 3  
Rotatable Bond Count: 2  
XLogP3: 1.9  

 

 

Upstream Synthesis Route
  • A versatile steroid compound, (11β,16α)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione plays a crucial role in chemical synthesis processes. With its unique structure, this compound serves as a key intermediate in the production of various pharmaceuticals, particularly corticosteroids. Its strategic placement of functional groups allows for targeted modifications and controlled reactions, making it a valuable tool for organic chemists. In the realm of medicinal chemistry, this compound serves as a foundational building block for the synthesis of potent glucocorticoids and other therapeutically important molecules. Its incorporation into synthetic routes enables the efficient production of drug candidates and facilitates further structural optimization for improved pharmacological properties. Additionally, (11β,16α)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione's utility extends to the research and development of novel steroid-based compounds with potential applications in various fields.
Literature
FEATURED PRODUCTS